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Abstract
Most of our knowledge of within host disease dynamics and immune
response comes from studies performed in mice or other laboratory an-
imals. These biological models have some natural advantages: genetic
similarity, identical medical history and synchronized time of infection.
Removing confounding variables has helped reveal many of the important
processes underlying infection and immunity. However, studies in inbred
mice can also be limiting precisely because they lack diversity. Many
mathematical models, making very different assumptions about the un-
derlying biology can be fit to the same data. Although these models
make similar predictions about for a single individual, they may make
quite different predictions about the difference that appear in population
of individuals. Therefore, we will likely benefit from fitting these models
to human data, and not just because of the increased clinical relevance.
The yellow fever vaccine establishes a short term infection in patients and
thus represents an ethical way to study viral dynamics and immune re-
sponse in humans. We find that we cannot distinguish between different
models when we fit to the mean data alone, but only when we consider
the differences between patients.
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